Tamibarotene

CAS No. 94497-51-5

Tamibarotene( Amnolake | NSC 608000 | Retinobenzoic Acid | Tamibarotene )

Catalog No. M16769 CAS No. 94497-51-5

Tamibarotene is a synthetic retinoic acid receptor (RAR) agonist with high specificity for RARα and RARβ over RARγ.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 In Stock
25MG 52 In Stock
50MG 65 In Stock
100MG 88 In Stock
200MG 140 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tamibarotene
  • Note
    Research use only, not for human use.
  • Brief Description
    Tamibarotene is a synthetic retinoic acid receptor (RAR) agonist with high specificity for RARα and RARβ over RARγ.
  • Description
    Tamibarotene is a synthetic retinoic acid receptor (RAR) agonist with high specificity for RARα and RARβ over RARγ.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Amnolake | NSC 608000 | Retinobenzoic Acid | Tamibarotene
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Retinoid Receptor
  • Recptor
    RARα| RARβ
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    94497-51-5
  • Formula Weight
    351.44
  • Molecular Formula
    C22H25NO3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 70 mg/mL (199.18 mM); DMSO: 70 mg/mL (199.18 mM)
  • SMILES
    O=C(O)C1=CC=C(C(NC2=CC=C3C(C)(C)CCC(C)(C)C3=C2)=O)C=C1
  • Chemical Name
    4-[(5,5,8,8-Tetramethyl-6,7-dihydronaphthalen-2-yl)carbamoyl]benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sanda T, et al. Leukemia, 2005, 19(6), 901-909.
molnova catalog
related products
  • Halofuginone

    Halofuginone, the competitive inhibitor of prolyl-tRNA synthetase(Ki=18.3 nM), could also down-regulate Smad3 and blocked TGF-β signaling at 10 ng/ml in the mammal.

  • MM 11253

    MM 11253 is a RARγ antagonist with IC50 of 44nM.

  • Bexarotene

    Bexarotene is a retinoid specifically selective for retinoid X receptors, used as an oral antineoplastic agent in the treatment of cutaneous T-cell lymphoma.